Japanese lung cancer research trends and performance in Science Citation Index.
暂无分享,去创建一个
[1] J. Minna,et al. Clinical and biological features associated with epidermal growth factor receptor gene mutations in lung cancers. , 2006, Journal of the National Cancer Institute.
[2] H. Bartelink,et al. Effects of concomitant cisplatin and radiotherapy on inoperable non-small-cell lung cancer. , 1992, The New England journal of medicine.
[3] Jing Zhang,et al. Assessment of world aerosol research trends by bibliometric analysis , 2008, Scientometrics.
[4] S. Kudoh,et al. Phase III study of concurrent versus sequential thoracic radiotherapy in combination with mitomycin, vindesine, and cisplatin in unresectable stage III non-small-cell lung cancer. , 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[5] S. Itohara,et al. Reduced angiogenesis and tumor progression in gelatinase A-deficient mice. , 1998, Cancer research.
[6] Yuh-Shan Ho,et al. Global stem cell research trend: Bibliometric analysis as a tool for mapping of trends from 1991 to 2006 , 2009, Scientometrics.
[7] Yuh-Shan Ho,et al. A bibliometric and citation analysis of stroke-related research in Taiwan , 2007, Scientometrics.
[8] T. Hirayama. Non-smoking wives of heavy smokers have a higher risk of lung cancer: a study from Japan. , 1981, British medical journal.
[9] O. Brodin,et al. Chemotherapy in non-small cell lung cancer: a meta-analysis using updated data on individual patients from 52 randomised clinical trials , 1995 .
[10] J. Sarkaria,et al. Inhibition of ATM and ATR kinase activities by the radiosensitizing agent, caffeine. , 1999, Cancer research.
[11] S. Gabriel,et al. EGFR Mutations in Lung Cancer: Correlation with Clinical Response to Gefitinib Therapy , 2004, Science.
[12] C. Mountain,et al. Revisions in the International System for Staging Lung Cancer. , 1997, Chest.
[13] Alfred J. Lotka,et al. The frequency distribution of scientific productivity , 1926 .
[14] Masahiro Fukuoka,et al. Multi-institutional randomized phase II trial of gefitinib for previously treated patients with advanced non-small-cell lung cancer (The IDEAL 1 Trial) [corrected]. , 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[15] N. Saijo,et al. Phase III study of concurrent versus sequential thoracic radiotherapy in combination with cisplatin and etoposide for limited-stage small-cell lung cancer: results of the Japan Clinical Oncology Group Study 9104. , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[16] N. Saijo,et al. Japan Clinical Oncology Group (JCOG). , 1998, Japanese journal of clinical oncology.
[17] J P Pignon,et al. A meta-analysis of thoracic radiotherapy for small-cell lung cancer. , 1992, The New England journal of medicine.
[18] R. Tsuchiya,et al. Prognosis and survival in resected lung carcinoma based on the new international staging system. , 1988, The Journal of thoracic and cardiovascular surgery.
[19] Yuh-Shan Ho,et al. Use of citation per publication as an indicator to evaluate pentachlorophenol research , 2008, Scientometrics.
[20] Yuh-Shan Ho,et al. Bibliometric Analysis of Adsorption Technology in Environmental Science , 2007 .
[21] K. Syrigos,et al. Developments in the treatment of non-small cell lung cancer. , 2007, Anticancer research.